Anthropometric Measures and Mortality Risk in Individuals With Metabolic Dysfunction‐Associated Steatotic Liver Disease (MASLD): A Population‐Based Cohort Study
- 14 May 2025
- journal article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 62 (2) , 168-179
Abstract
Background/Aims: As the primary anthropometric measure in metabolic dysfunction‐associated steatotic liver disease (MASLD), waist circumference (WC) may more accurately reflect the visceral fat distribution than body mass index (BMI). This study aimed to compare the prognostic value of BMI, WC and WC‐related indices including waist‐hip ratio (WHR), body shape index (BSI) and weight‐adjusted‐waist index (WWI) in individuals with MASLD.Methods: The study population was derived from four large‐scale cohorts: the National Health and Nutrition Examination Survey (NHANES 2017–2020 and NHANES III), the Kailuan Cohort and the UK Biobank Cohort. We evaluated the mortality risk across these measures using multivariate Cox proportional hazards regression and restrictive cubic spline.Results: The Pearson correlation coefficient of WC with hepatic steatosis and fibrosis was better than that of BMI. WC [Quartile 4 vs. Quartile 1: HR (hazard ratio) = 1.48 (95% confidence interval (CI) 1.13–1.93)] and WC‐related indices [Quartile 4 vs. Quartile 1: WHR HR = 3.21 (95% CI 2.36–4.37); BSI HR = 3.22 (95% CI 2.48–4.17); WWI HR = 4.72 (95% CI 3.36–6.62)], but not BMI [obesity vs. lean: HR = 0.90 (95% CI 0.72–1.12)], indicated a significant mortality risk gradient among individuals with MASLD. The finding was consistent across sex and racial/ethnic subgroups, with external validation supporting the WC‐related indices. MASLD and fibrosis prevalence showed a dose‐dependent pattern across WC‐related index quartiles. Notably, low BMI and high WC‐related indices portended the highest mortality risk.Conclusions: WC and WC‐related indices are better parameters in prognosticating MASLD than BMI. The BMI‐related ‘obesity paradox’ may be a misnomer resulting from the use of an incorrect metric. WC should be measured more routinely among individuals with MASLD.Keywords
Funding Information
- Natural Science Foundation of Jiangsu Province (BK20231118)
- National Natural Science Foundation of China (81970545, 82170609)
This publication has 40 references indexed in Scilit:
- Strengths and Limitations of BMI in the Diagnosis of Obesity: What is the Path Forward?Current Obesity Reports, 2024
- Anthropometric indicators of adiposity and risk of primary liver cancer: A systematic review and dose–response meta-analysisEuropean Journal of Cancer, 2023
- 2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysisClinical Gastroenterology and Hepatology, 2022
- Enhanced diagnosis of advanced fibrosis and cirrhosis in individuals with NAFLD using FibroScan-based Agile scoresJournal of Hepatology, 2022
- Prevalence, characteristics, and mortality outcomes of obese and nonobese MAFLD in the United StatesHepatology International, 2022
- Pathogenesis of sarcopenia and the relationship with fat mass: descriptive reviewJournal of Cachexia, Sarcopenia and Muscle, 2022
- Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic AdaptationHepatology, 2019
- Does selection bias explain the obesity paradox among individuals with cardiovascular disease?Annals of Epidemiology, 2015
- Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver diseaseDigestive and Liver Disease, 2010
- Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfectionHepatology, 2006